Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Sarepta Therapeutics Inc (SRPT)  
$128.77 1.38 (1.08%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 84,190,000
Market Cap: 10.84(B)
Last Volume: 427,350 Avg Vol: 426,157
52 Week Range: $67.31 - $157.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 16.7
Insider 3/6 Months : 17.3
Guru Rank Number :  983
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Co. is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy, Limb-girdle muscular dystrophies and other neuromuscular and central nervous system related disorders. Co.'s commercial product, EXONDYS 51® (eteplirsen) Injection is indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 75,225 143,757 247,027
Total Buy Value $0 $5,942,300 $13,295,068 $24,257,422
Total People Bought 0 2 3 3
Total Buy Transactions 0 2 5 7
Total Shares Sold 24,096 24,096 39,096 39,954
Total Sell Value $2,990,141 $2,990,141 $4,590,941 $4,685,252
Total People Sold 6 6 6 6
Total Sell Transactions 6 6 7 8
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 360
  Page 2 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Brown Ryan Edward EVP, General Counsel   •       –      –    2024-03-01 4 D $126.19 $33,945 D/D (269) 27,827     -
   Arif Bilal Chief Tech Ops Officer   •       –      –    2024-03-01 4 D $126.19 $46,059 D/D (365) 26,722     -
   Arif Bilal Chief Tech Ops Officer   •       –      –    2024-03-01 4 S $128.58 $257,676 D/D (2,000) 26,836 1%     
   Arif Bilal Chief Tech Ops Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 6,000 28,836     -
   Behrens M Kathleen   –       •      –    2024-03-01 4 A $0.00 $0 D/D 1,846 176,839     -
   Barry Richard   –       •      –    2024-03-01 4 A $0.00 $0 D/D 1,846 2,931,688     -
   Estepan Ian Michael Chief Financial Officer   •       –      –    2024-03-01 4 S $128.30 $153,960 D/D (1,200) 39,114 1%     
   Estepan Ian Michael Chief Financial Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 6,000 40,314     -
   Estepan Ian Michael Chief Financial Officer   •       –      –    2024-03-01 4 D $126.19 $46,059 D/D (365) 34,314     -
   Arif Bilal Chief Tech Ops Officer   •       –      –    2023-12-01 4 D $80.34 $295,812 D/D (3,682) 22,886     -
   Rodino-Klapac Louise Head of R&D, CSO   •       –      –    2023-11-17 4 D $82.98 $374,074 D/D (4,508) 65,751     -
   Behrens M Kathleen Director   –       •      –    2023-11-03 4 OE $29.03 $435,450 D/D 15,000 174,993     -
   Ingram Douglas S President & CEO   •       •      –    2023-11-03 4 B $78.57 $2,001,800 D/D 25,225 390,307 2.81 58%     
   Barry Richard Director   –       •      –    2023-11-03 4 B $78.81 $3,940,500 I/I 50,000 140,000 2.1 58%     
   Chambers Michael Andrew Director   –       •      –    2023-08-14 4 B $109.19 $1,092,429 I/I 9,979 246,996 2.1 -20%     
   Chambers Michael Andrew Director   –       •      –    2023-08-11 4 B $108.05 $2,559,272 I/I 23,686 237,017 2.1 -12%     
   Chambers Michael Andrew Director   –       •      –    2023-08-10 4 B $104.67 $3,701,067 I/I 34,867 213,331 2.1 -11%     
   Wigzell Hans Lennart Rudolf Director   –       •      –    2023-08-04 4 S $106.72 $1,600,800 D/D (15,000) 20,994 18%     
   Wigzell Hans Lennart Rudolf Director   –       •      –    2023-08-04 4 OE $29.03 $435,450 D/D 15,000 35,994     -
   Brown Ryan Edward EVP, General Counsel   •       –      –    2023-06-01 4 D $123.60 $11,000 D/D (89) 28,096     -
   Arif Bilal Chief Tech Ops Officer   •       –      –    2023-03-08 4 D $153.19 $48,102 D/D (314) 26,674     -
   Rodino-Klapac Louise Head of R&D, CSO   •       –      –    2023-03-08 4 D $153.19 $139,709 D/D (912) 70,170     -
   Brown Ryan Edward SVP, General Counsel   •       –      –    2023-03-08 4 D $153.19 $97,276 D/D (635) 28,185     -
   Estepan Ian Michael Chief Financial Officer   •       –      –    2023-03-08 4 D $153.19 $113,973 D/D (744) 34,679     -
   Rodino-Klapac Louise Head of R&D, CSO   •       –      –    2023-03-06 4 A $0.00 $0 D/D 4,500 71,082     -
  360 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us